Literature DB >> 2536518

Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation.

J D Pirsch1, R J Stratta, H W Sollinger, G R Hafez, A M D'Alessandro, M Kalayoglu, F O Belzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2536518     DOI： 10.1016/0002-9343(89)90279-9

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  12 in total

1.  A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Authors:  Susan P Perrine; Olivier Hermine; Trudy Small; Felipe Suarez; Richard O'Reilly; Farid Boulad; Joyce Fingeroth; Melissa Askin; Arthur Levy; Steven J Mentzer; Massimo Di Nicola; Alessandro M Gianni; Christoph Klein; Steven Horwitz; Douglas V Faller
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

Review 2.  Lymphoproliferative disease in organ transplant recipients.

Authors:  M A Nalesnik
Journal:  Springer Semin Immunopathol       Date:  1991

3.  Substrate specificity of Epstein-Barr virus thymidine kinase.

Authors:  P P Tung; W C Summers
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

4.  How should we treat transplanted children with subsequent malignancies such as lymphoma?

Authors:  M Broyer
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

Review 5.  Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy.

Authors:  Andrew M Evens; Rupali Roy; Danielle Sterrenberg; Michelle Z Moll; Amy Chadburn; Leo I Gordon
Journal:  Curr Oncol Rep       Date:  2010-11       Impact factor: 5.075

6.  Anti-Epstein-Barr virus (EBV) activity of beta-L-5-iododioxolane uracil is dependent on EBV thymidine kinase.

Authors:  T Kira; S P Grill; G E Dutschman; J S Lin; F Qu; Y Choi; C K Chu; Y C Cheng
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

7.  Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder.

Authors:  D E Tsai; E A Stadtmauer; D J Canaday; D J Vaughn
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

Review 8.  The therapy of primary brain lymphoma.

Authors:  F H Hochberg; J S Loeffler; M Prados
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

9.  Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone.

Authors:  James P Dugan; Bradley M Haverkos; Lynda Villagomez; Ludmila K Martin; Mark Lustberg; John Patton; Marisa Martin; Ying Huang; Gerard Nuovo; Fengting Yan; Robert Cavaliere; Joyce Fingeroth; Shannon C Kenney; Richard F Ambinder; Gerard Lozanski; Pierluigi Porcu; Michael A Caligiuri; Robert A Baiocchi
Journal:  Clin Cancer Res       Date:  2018-04-09       Impact factor: 12.531

10.  The Effect of Antiretroviral Combination Treatment on Epstein-Barr Virus (EBV) Genome Load in HIV-Infected Patients.

Authors:  Anna M C Friis; Katarina Gyllensten; Anna Aleman; Ingemar Ernberg; Börje Åkerlund
Journal:  Viruses       Date:  2010-03-29       Impact factor: 5.818
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.